TNXP · ISSUER CIK 1430306
Tonix Pharmaceuticals Holding Corp.
Between Aug 1, 2026 and Oct 29, 2026, 2 Tonix Pharmaceuticals Holding Corp. insiders reported $40K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was Lederman Seth (Chief Executive Officer, Director), with $28K.
↗2 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. No open-market sales in the window.
$40KInsider buying
$0.00Insider selling
+$40KNet open-market
Aug 31, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 31, 202608:00 | Aug 27, 2026 | TNXP | Chief Executive Officer, Director | P · Buy | $13.79 | +2,000 | 11,005 | +22% | +$28K | +0.9% | -61.7% |
| Aug 24, 202608:00 | Aug 20, 2026 | TNXP | Director | P · Buy | $12.60 | +1,000 | 1,000 | New | +$13K | -4.7% | -58.1% |